Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pediatric Vaccine Effectiveness Against Influenza Hospitalization and Outpatient Visits: 2021-2024.
Olson SM, Ahmad HM, Wielgosz K, Michaels MG, Williams JV, Englund JA, Klein EJ, Staat MA, Schlaudecker EP, Weinberg GA, Szilagyi PG, Sahni LC, Boom JA, Halasa NB, Stewart LS, Selvarangan R, Schuster JE, DaSilva J, Keong LM, Kirby MK, Toepfer AP, Moline HL, Ellington S. Olson SM, et al. Among authors: toepfer ap. Pediatrics. 2026 May 1;157(5):e2025073973. doi: 10.1542/peds.2025-073973. Pediatrics. 2026. PMID: 41936402
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter EB, Michaels MG, Staat MA, Weinberg GA, Selvarangan R, Boom JA, Klein EJ, Halasa NB, Ginde AA, Gibbs KW, Zhu Y, Self WH, Tartof SY, Klein NP, Dascomb K, DeSilva MB, Weber ZA, Yang DH, Ball SW, Surie D, DeCuir J, Dawood FS, Moline HL, Toepfer AP, Clopper BR, Link-Gelles R, Payne AB, Chung JR, Flannery B, Lewis NM, Olson SM, Adams K, Tenforde MW, Garg S, Grohskopf LA, Reed C, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators. Frutos AM, et al. Among authors: toepfer ap. MMWR Morb Mortal Wkly Rep. 2024 Feb 29;73(8):168-174. doi: 10.15585/mmwr.mm7308a3. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38421935 Free PMC article.
Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022.
McMorrow ML, Moline HL, Toepfer AP, Halasa NB, Schuster JE, Staat MA, Williams JV, Klein EJ, Weinberg GA, Clopper BR, Boom JA, Stewart LS, Selvarangan R, Schlaudecker EP, Michaels MG, Englund JA, Albertin CS, Mahon BE, Hall AJ, Sahni LC, Curns AT. McMorrow ML, et al. Among authors: toepfer ap. Pediatrics. 2024 Jul 1;154(1):e2023065623. doi: 10.1542/peds.2023-065623. Pediatrics. 2024. PMID: 38841769 Free PMC article.
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
Moline HL, Toepfer AP, Tannis A, Weinberg GA, Staat MA, Halasa NB, Boom JA, Klein EJ, Williams JV, Schuster JE, Goldstein L, McKeever ER, Kalman C, Paden C, Atherton L, Aggarwal M, Roychoudhury P, Piedra PA, Sahni LC, Stewart LS, Selvarangan R, Michaels MG, Schlaudecker EP, Szilagyi PG, Englund JA, Clopper BR, Thornburg NJ, Derado G, McMorrow ML, Dawood FS; New Vaccine Surveillance Network Collaborators. Moline HL, et al. Among authors: toepfer ap. JAMA Pediatr. 2025 Feb 1;179(2):179-187. doi: 10.1001/jamapediatrics.2024.5572. JAMA Pediatr. 2025. PMID: 39652359 Free PMC article.
Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020.
Stopczynski T, Amarin JZ, Antoon JW, Hamdan O, Stewart LS, Chappell J, Spieker AJ, Klein EJ, Englund JA, Weinberg GA, Szilagyi PG, Williams JV, Michaels MG, Boom JA, Sahni LC, Staat MA, Schlaudecker EP, Schuster JE, Selvarangan R, Harrison CJ, Moline HL, Toepfer AP, Campbell AP, Olson SM, Halasa NB. Stopczynski T, et al. Among authors: toepfer ap. Influenza Other Respir Viruses. 2025 Jun;19(6):e70124. doi: 10.1111/irv.70124. Influenza Other Respir Viruses. 2025. PMID: 40495453 Free PMC article.
Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis.
Goldstein LA, Michaels MG, Salthouse A, Toepfer AP, Musa S, Hickey RW, Johnson M, Wang-Erickson AF, Weinberg GA, Szilagyi PG, Schlaudecker EP, Staat MA, Sahni LC, Boom JA, Klein EJ, Englund JA, Schuster JE, Selvarangan R, Harrison CJ, Halasa NB, Stewart LS, Dawood FS, Moline HL, Williams JV. Goldstein LA, et al. Among authors: toepfer ap. Pediatrics. 2025 Sep 1;156(3):e2024070218. doi: 10.1542/peds.2024-070218. Pediatrics. 2025. PMID: 40763933 Free PMC article.
Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children.
Moline HL, Tannis A, Goldstein L, Englund JA, Staat MA, Boom JA, Selvarangan R, Michaels MG, Weinberg GA, Halasa NB, Toepfer AP, Rutkowski RE, Salthouse A, Sahni LC, Schuster JE, Stewart LS, Williams JV, Payne DC, Klein EJ, Szilagyi PG, Dawood FS; New Vaccine Surveillance Network Collaborators. Moline HL, et al. Among authors: toepfer ap. JAMA Pediatr. 2026 Mar 1;180(3):314-324. doi: 10.1001/jamapediatrics.2025.5778. JAMA Pediatr. 2026. PMID: 41428480
Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2 Years Hospitalized With RSV.
Salthouse AL, Tannis A, Rutkowski RE, Weinberg GA, Szilagyi PG, Staat MA, Schlaudecker E, Halasa NB, Stewart LS, Boom JA, Sahni LC, Michaels MG, Schuster JE, Selvarangan R, Klein EJ, Englund JA, Williams JV, Toepfer A, Moline HL, Dawood FS. Salthouse AL, et al. Pediatrics. 2026 Feb 1;157(2):e2025072578. doi: 10.1542/peds.2025-072578. Pediatrics. 2026. PMID: 41500499
Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic.
Hamdan O, Amarin JZ, Antoon JW, Stopczynski T, Stewart LS, Klein EJ, Englund JA, Weinberg GA, Szilagyi PG, Williams JV, Michaels MG, Boom JA, Sahni LC, Staat MA, Schlaudecker EP, Schuster JE, Selvarangan R, Toepfer AP, Moline HL, Chappell JD, Spieker AJ, Olson SM, Halasa NB. Hamdan O, et al. Among authors: toepfer ap. Pediatrics. 2026 Feb 1;157(2):e2025071898. doi: 10.1542/peds.2025-071898. Pediatrics. 2026. PMID: 41529813
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
Moline HL, Tannis A, Toepfer AP, Williams JV, Boom JA, Englund JA, Halasa NB, Staat MA, Weinberg GA, Selvarangan R, Michaels MG, Sahni LC, Klein EJ, Stewart LS, Schlaudecker EP, Szilagyi PG, Schuster JE, Goldstein L, Musa S, Piedra PA, Zerr DM, Betters KA, Rohlfs C, Albertin C, Banerjee D, McKeever ER, Kalman C, Clopper BR; New Vaccine Surveillance Network Product Effectiveness Collaborators; McMorrow ML, Dawood FS. Moline HL, et al. Among authors: toepfer ap. MMWR Morb Mortal Wkly Rep. 2024 Mar 7;73(9):209-214. doi: 10.15585/mmwr.mm7309a4. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38457312 Free PMC article.
22 results